Literature DB >> 25932111

Abnormal expression of NSF, α-SNAP and SNAP23 in pulmonary arterial hypertension in rats treated with monocrotaline.

Hong-Liang Zhang1, Zhi-Hong Liu1, Qin Luo1, Yong Wang1, Zhi-Hui Zhao1.   

Abstract

BACKGROUND: Recent researches have shown that dysfunctional intracellular vesicular trafficking exists in pulmonary arterial hypertension (PAH). However, the expression of proteins involved in intracellular vesicular trafficking in pulmonary vasculature in PAH remains unclear.
OBJECTIVE: To elucidate possible roles of proteins involved in intracellular vesicular trafficking in the development of PAH in rats treated with monocrotaline, changes in the expression of N-ethyl-maleimide-sensitive factor (NSF), α-soluble NSF attachment protein (α-SNAP) and synaptosome-associated membrane protein (SNAP) 23 were examined together with expression of caveolin-1 (cav-1), endogenous nitric oxide synthase (eNOS), type 2 bone morphogenetic receptor (BMPR2) and cellular apoptosis.
METHODS: The mRNA expression was investigated by real time-PCR and protein expression by immunoblot method in rat lung. Caspase-3 was used as an indicator of cellular apoptosis and examined by immunoblot method.
RESULTS: During the development of PAH, mRNA and protein expression of NSF, α-SNAP and SNAP23 all significantly increased before pulmonary arterial pressure started to increase, then all significantly decreased when PAH established. The expression of eNOS and BMPR2 changed similarly, while the mRNA and protein of cav-1 both downregulated after monocrotaline treatment. Caspase-3 was also increased after exposure to monocrotaline.
CONCLUSIONS: Since the expression of NSF, α-SNAP and SNAP23 changed greatly during the onset of PAH and accompanied with abnormal expression of eNOS, BMPR2 and cav-1 and with enhanced cellular apoptosis, NSF, α-SNAP and SNAP23 appear to be associated with the development of PAH in rats treated with monocrotaline.

Entities:  

Keywords:  Pulmonary arterial hypertension; intracellular vesicular trafficking; monocrotaline

Year:  2015        PMID: 25932111      PMCID: PMC4402758     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  37 in total

1.  Cholesterol-dependent syntaxin-4 and SNAP-23 clustering regulates caveolar fusion with the endothelial plasma membrane.

Authors:  Sanda A Predescu; Dan N Predescu; Kayo Shimizu; Irene K Klein; Asrar B Malik
Journal:  J Biol Chem       Date:  2005-08-23       Impact factor: 5.157

2.  An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry.

Authors:  Raymond L Benza; Dave P Miller; Robyn J Barst; David B Badesch; Adaani E Frost; Michael D McGoon
Journal:  Chest       Date:  2012-08       Impact factor: 9.410

Review 3.  SNAREs--engines for membrane fusion.

Authors:  Reinhard Jahn; Richard H Scheller
Journal:  Nat Rev Mol Cell Biol       Date:  2006-08-16       Impact factor: 94.444

4.  Live cell imaging of interleukin-6-induced targeting of "transcription factor" STAT3 to sequestering endosomes in the cytoplasm.

Authors:  Fang Xu; Somshuvra Mukhopadhyay; Pravin B Sehgal
Journal:  Am J Physiol Cell Physiol       Date:  2007-08-01       Impact factor: 4.249

5.  Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor.

Authors:  Carl Atkinson; Susan Stewart; Paul D Upton; Rajiv Machado; Jennifer R Thomson; Richard C Trembath; Nicholas W Morrell
Journal:  Circulation       Date:  2002-04-09       Impact factor: 29.690

6.  Aberrant cytoplasmic sequestration of eNOS in endothelial cells after monocrotaline, hypoxia, and senescence: live-cell caveolar and cytoplasmic NO imaging.

Authors:  Somshuvra Mukhopadhyay; Fang Xu; Pravin B Sehgal
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-10-27       Impact factor: 4.733

7.  Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.

Authors:  A Giaid; D Saleh
Journal:  N Engl J Med       Date:  1995-07-27       Impact factor: 91.245

8.  Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice.

Authors:  You-Yang Zhao; Yang Liu; Radu-Virgil Stan; Lian Fan; Yusu Gu; Nancy Dalton; Po-Hsien Chu; Kirk Peterson; John Ross; Kenneth R Chien
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

9.  Functional heterogeneity of bone morphogenetic protein receptor-II mutants found in patients with primary pulmonary hypertension.

Authors:  Ayako Nishihara; Tetsuro Watabe; Takeshi Imamura; Kohei Miyazono
Journal:  Mol Biol Cell       Date:  2002-09       Impact factor: 4.138

10.  Variable expression of endothelial NO synthase in three forms of rat pulmonary hypertension.

Authors:  R C Tyler; M Muramatsu; S H Abman; T J Stelzner; D M Rodman; K D Bloch; I F McMurtry
Journal:  Am J Physiol       Date:  1999-02
View more
  2 in total

1.  SNAP23 promotes the malignant process of ovarian cancer.

Authors:  Qi Sun; Xing Huang; Quanli Zhang; Junwei Qu; Yang Shen; Xin Wang; Haijun Sun; Jie Wang; Lin Xu; Xiaoxiang Chen; Binhui Ren
Journal:  J Ovarian Res       Date:  2016-11-17       Impact factor: 4.234

2.  Rare variants in RNF213, a susceptibility gene for moyamoya disease, are found in patients with pulmonary hypertension and aggravate hypoxia-induced pulmonary hypertension in mice.

Authors:  Hatasu Kobayashi; Risako Kabata; Hideyuki Kinoshita; Takaaki Morimoto; Koh Ono; Midori Takeda; Jungmi Choi; Hiroko Okuda; Wanyang Liu; Kouji H Harada; Takeshi Kimura; Shohab Youssefian; Akio Koizumi
Journal:  Pulm Circ       Date:  2018-05-02       Impact factor: 3.017

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.